应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
SNY 赛诺菲安万特
休市中 12-19 16:00:00 EST
48.18
+0.19
+0.40%
盘后
48.18
+0.00
0.00%
18:23 EST
最高
48.45
最低
47.70
成交量
306.95万
今开
47.71
昨收
47.99
日振幅
1.56%
总市值
1,170亿
流通市值
1,058亿
总股本
24.29亿
成交额
1.48亿
换手率
0.14%
流通股本
21.97亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
默沙东(MRK.US)、施贵宝(BMY.US)等多家药企同意下调美国药价 以换取特朗普政府关税豁免和政策支持
智通财经 · 12-20 07:00
默沙东(MRK.US)、施贵宝(BMY.US)等多家药企同意下调美国药价 以换取特朗普政府关税豁免和政策支持
美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易
美股速递 · 12-20 03:22
美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易
创新药研发充满荆棘,近期多家药企接连宣布“折戟”
制药网 · 12-18 16:06
创新药研发充满荆棘,近期多家药企接连宣布“折戟”
赛诺菲(SNY.US)宣布第二代心肌肌球蛋白抑制剂在华获批上市
智通财经 · 12-17
赛诺菲(SNY.US)宣布第二代心肌肌球蛋白抑制剂在华获批上市
1天两笔交易,超26亿美元!制药巨头抢滩自免赛道
医药魔方 · 12-16
1天两笔交易,超26亿美元!制药巨头抢滩自免赛道
FDA延期叠加试验失败,赛诺菲多发性硬化症药物遭双重暴击
智通财经 · 12-15
FDA延期叠加试验失败,赛诺菲多发性硬化症药物遭双重暴击
独家报道:美国FDA官员通知默沙东、赛诺菲安万特和阿斯利康的RSV抗体疗法将接受新的安全审查
美股速递 · 12-09
独家报道:美国FDA官员通知默沙东、赛诺菲安万特和阿斯利康的RSV抗体疗法将接受新的安全审查
旗舰药物需求增长,赛诺菲安万特三季度利润超预期
智通财经 · 10-24
旗舰药物需求增长,赛诺菲安万特三季度利润超预期
EMA十月药品审评会议:赛诺菲(SNY.US)、Insmed(INSM.US)等公司新药获上市推荐
智通财经 · 10-17
EMA十月药品审评会议:赛诺菲(SNY.US)、Insmed(INSM.US)等公司新药获上市推荐
赛诺菲(SNY.US)TSLP/IL-13双抗启动COPD II/III期临床
智通财经 · 09-26
赛诺菲(SNY.US)TSLP/IL-13双抗启动COPD II/III期临床
赛诺菲(SNY.US)全球首创OX40L单抗III期研究成功
智通财经网 · 09-04
赛诺菲(SNY.US)全球首创OX40L单抗III期研究成功
美股异动 | 赛诺菲(SNY.US)盘前跌近9% 特应性皮炎药物后期试验疗效不及预期
智通财经 · 09-04
美股异动 | 赛诺菲(SNY.US)盘前跌近9% 特应性皮炎药物后期试验疗效不及预期
美股异动丨赛诺菲盘前大跌超9%,OX40L数据不及预期
格隆汇 · 09-04
美股异动丨赛诺菲盘前大跌超9%,OX40L数据不及预期
赛诺菲安万特股价因实验药物结果不佳而下跌
老虎资讯综合 · 09-04
赛诺菲安万特股价因实验药物结果不佳而下跌
医药巨头赛诺菲安万特盘前大跌超8%公司新型湿疹药物试验结果表现不佳;特朗普家族旗下比特币矿商American Bitco
智通财经 · 09-04
医药巨头赛诺菲安万特盘前大跌超8%公司新型湿疹药物试验结果表现不佳;特朗普家族旗下比特币矿商American Bitco
赛诺菲(SNY.US)的Amlitelimab在3期研究中达到所有主要和关键次要目标。
格隆汇 · 09-04
赛诺菲(SNY.US)的Amlitelimab在3期研究中达到所有主要和关键次要目标。
美股生物医药股全线下跌!特朗普再放狠话:下调药品价格1400%至1500%
智通财经 · 08-26
美股生物医药股全线下跌!特朗普再放狠话:下调药品价格1400%至1500%
赛诺菲安万特8月11日成交额为1.31亿美元
市场透视 · 08-12
赛诺菲安万特8月11日成交额为1.31亿美元
赛诺菲安万特8月8日成交额为1.40亿美元
市场透视 · 08-09
赛诺菲安万特8月8日成交额为1.40亿美元
赛诺菲安万特8月7日成交额为1.73亿美元
市场透视 · 08-08
赛诺菲安万特8月7日成交额为1.73亿美元
加载更多
公司概况
公司名称:
赛诺菲安万特
所属市场:
NASDAQ
上市日期:
--
主营业务:
Sanofi于1994年根据法国法律注册成立。该公司是一家全球领先的医疗保健公司,专注于患者需求并从事治疗解决方案的研究、开发、制造和营销。该公司的活动围绕以下类别组织:DUPIXENT、神经病学&免疫学、罕见病、肿瘤学、罕见血液病、普药核心资产和非核心资产、疫苗、CHC。
发行价格:
--
{"stockData":{"symbol":"SNY","market":"US","secType":"STK","nameCN":"赛诺菲安万特","latestPrice":48.18,"timestamp":1766178000000,"preClose":47.99,"halted":0,"volume":3069547,"hourTrading":{"tag":"盘后","latestPrice":48.18,"preClose":48.18,"latestTime":"18:23 EST","volume":242161,"amount":11667309.7948,"timestamp":1766186599264},"delay":0,"floatShares":2196882861,"shares":2429000000,"eps":4.336122,"marketStatus":"休市中","change":0.19,"latestTime":"12-19 16:00:00 EST","open":47.71,"high":48.45,"low":47.7,"amount":147933901.59535,"amplitude":0.015628,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":4.336122,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1766394000000},"marketStatusCode":7,"adr":1,"adrRate":0.5,"listingDate":1025496000000,"exchange":"NASDAQ","adjPreClose":47.99,"dividendRate":0.04725,"preHourTrading":{"tag":"盘前","latestPrice":47.72,"preClose":47.99,"latestTime":"09:29 EST","volume":2663,"amount":127433.23138,"timestamp":1766154570066},"postHourTrading":{"tag":"盘后","latestPrice":48.18,"preClose":48.18,"latestTime":"18:23 EST","volume":242161,"amount":11667309.7948,"timestamp":1766186599264},"volumeRatio":0.9941107118355866,"impliedVol":0.2532,"impliedVolPercentile":0.164},"requestUrl":"/m/hq/s/SNY","defaultTab":"news","newsList":[{"id":"2592139231","title":"默沙东(MRK.US)、施贵宝(BMY.US)等多家药企同意下调美国药价 以换取特朗普政府关税豁免和政策支持","url":"https://stock-news.laohu8.com/highlight/detail?id=2592139231","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592139231?lang=zh_cn&edition=full","pubTime":"2025-12-20 07:00","pubTimestamp":1766185200,"startTime":"0","endTime":"0","summary":"美国总统特朗普推动将美国药价与海外低价市场挂钩之际,多家美国及欧洲大型制药企业近日与白宫达成协议,同意自愿下调在美销售的药品价格,以换取关税豁免和政策支持。在此次协议中,最受市场关注的是施贵宝的让利承诺。特朗普在周五的公开活动上表示,今年7月他致信要求降价的17家大型制药企业中,已有14家同意大幅下调药价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384042.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1074936037.SGD","LU1057294990.SGD","LU0106261372.USD","LU0208291251.USD","LU0648001328.SGD","LU1670710588.SGD","GSK","BK4007","LU1989772923.USD","LU2023250504.SGD","LU1670711123.USD","LU2461242641.AUD","LU1162221912.USD","LU0061475181.USD","BK4516","SG9999013999.USD","LU0306807586.USD","LU0289739699.SGD","LU2125154778.USD","LU1868837300.USD","ROG","LU0070302665.USD","LU0985320562.USD","LU1061106388.HKD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0265550946.USD","LU1261432733.SGD","LU0234572021.USD","BK4534","LU2089984988.USD","SGXZ57979304.SGD","AZN","LU1934455863.HKD","LU1035773651.USD","SG9999014542.SGD","IE000M9KFDE8.USD","IE0002141913.USD","BK4550","LU1718418525.SGD","SG9999002232.USD","ABBV","SG9999014559.SGD","LU2125154935.USD","LU1066053197.SGD","LU0266013472.USD","LU1066051811.HKD","LU1934455277.USD","SG9999001176.SGD","LU0320765646.SGD","LU0211331839.USD","IE00BBT3K403.USD","LU1291159041.SGD","LU1037948897.HKD","AMGN","BK4581","IE00BFXG1179.USD","LU0306806265.USD","LU0203345920.USD","SG9999001440.SGD","LU1585245621.USD","LU0006306889.USD","LU1868837136.USD","LU1037948541.HKD","LU0965508806.USD","MRK","SNY","BMY","LU1116320901.HKD","SG9999015358.SGD","LU1868836591.USD","IE00B4R5TH58.HKD","REGN","LU0098860793.USD","LU1868836757.USD","LU0267386448.USD","IE00B1BXHZ80.USD","LU1430594728.SGD","JNJ","IE0009355771.USD","LU1941712348.USD","LU2361044949.HKD","BK4532","LU1116320737.USD","SG9999015341.SGD","LU0122379950.USD","LU0058720904.USD","LU2360032135.SGD","LU1929549753.HKD","LU2133065610.SGD","LU0868494617.USD","IE00BLSP4452.SGD","LU1989772840.SGD","IE00B2B36J28.USD","LU1571399168.USD","BK4559","LU0114720955.EUR","LU2324357040.USD","LU1093756168.USD","LU0130517989.USD","LU0203347892.USD","LU0321505439.SGD","LU0321505868.SGD","BK4585","LU1917777945.USD","LU1934455194.USD","LU0456855351.SGD","IE00BJJMRZ35.SGD","LU0985481810.HKD","LU1023059063.AUD","LU2242652126.USD","SG9999014567.USD","BK4588","LU2242646821.SGD","SG9999014575.USD","LU1670710661.SGD","IE00BN8TJ469.HKD","IE00BSNM7G36.USD","LU0965509010.AUD","LU1066051225.USD","LU0238689110.USD","LU1032466523.USD","LU2361045086.USD","LU0882574055.USD","SG9999001176.USD","LU2023250843.SGD","IE00BLSP4239.USD","LU1974910355.USD","LU2468319806.SGD","LU0320765489.SGD","LU0965509101.SGD","LU1699723380.USD","LU0980610538.SGD","LU1989771016.USD","LU0225284248.USD","LU1093756325.SGD","LU0096364046.USD","SG9999002224.SGD","LU0130102774.USD","LU1983299246.USD","NVS","LU0965509283.SGD","LU2361044865.SGD","LU1868836914.USD","LU0265550359.USD","BK4533","LU0477156953.USD","LU1066051498.USD","LU0225771236.USD","LU2112291526.USD","LU2106854487.HKD","LU1323610961.USD","LU1069347547.HKD","LU1670711040.USD","LU1941712264.USD","LU0861579265.USD","LU0237698245.USD","04332","GILD","LU1201861249.SGD"],"gpt_icon":1},{"id":"1190397083","title":"美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1190397083","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190397083?lang=zh_cn&edition=full","pubTime":"2025-12-20 03:22","pubTimestamp":1766172127,"startTime":"0","endTime":"0","summary":"美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","SG9999015952.SGD","LU1699723380.USD","LU0238689110.USD","LU1015430645.USD","BK4566","LU0161305163.EUR","SG9999013999.USD","LU1670710588.SGD","NVS","BMY","LU1778281490.HKD","LU0096364046.USD","BIIB","IE00BSNM7G36.USD","LU0265550359.USD","SG9999014542.SGD","SG9999015341.SGD","IE00BJJMRZ35.SGD","IE000M9KFDE8.USD","LU1645745479.HKD","LU0114720955.EUR","BK4534","BK4585","LU0320765992.SGD","LU1035777561.USD","LU2461242641.AUD","IE0034235071.USD","BK4559","LU0477156953.USD","LU1046248800.SGD","BK4532","LU1989772923.USD","LU2023250504.SGD","IE00B19Z3581.USD","SG9999015945.SGD","SNY","LU0985320562.USD","IE00B1BXHZ80.USD","IE00BQJZX424.USD","LU1868837136.USD","LU1983299246.USD","IE00B3T34201.USD","LU1670711123.USD","IE0002141913.USD","LU1941712264.USD","LU1941712348.USD","LU0234572021.USD","BK4007","LU0203347892.USD","LU1309081286.SGD","LU1571399168.USD","LU1670710661.SGD","LU2023250843.SGD","LU1098665638.USD","LU1934455194.USD","LU1868837300.USD","LU1430594728.SGD","LU0889565916.HKD","LU0545562505.USD","LU0211331839.USD","IE00BN8TJ469.HKD","LU0289739699.SGD","LU0225284248.USD","LU1302929846.USD","SGXZ57979304.SGD","IE00B7SZLL34.SGD","LU1585245621.USD","LU1057294990.SGD","LU1035773651.USD","LU1066051225.USD","LU1989772840.SGD","GSK","LU0225771236.USD","IE00B19Z3B42.SGD","LU0306807586.USD","LU1868836757.USD","LU1989771016.USD","MRK","LU0006306889.USD","LU0985481810.HKD","LU2242646821.SGD","LU1934455277.USD","LU0109981661.USD","LU1261432733.SGD","LU0266013472.USD","LU1116320901.HKD","LU1670756490.USD","LU1074936037.SGD","IE0002270589.USD","LU1400636574.HKD","LU1066053197.SGD","LU0203345920.USD","04332","LU0070302665.USD","LU0130102774.USD","LU2125154778.USD","LU1061106388.HKD","LU0971552673.USD","LU0971552830.HKD","SG9999001176.USD","LU1400636491.USD","LU0648001328.SGD","LU0456855351.SGD","LU2242652126.USD","BK4533","LU1066051498.USD","LU0575583348.USD","LU1674673691.USD","LU1718418525.SGD","LU1839511570.USD","LU0122379950.USD","LU2361045086.USD","BK4583","LU1066051811.HKD","LU1037948897.HKD","IE00BJT1NW94.SGD","LU0965508806.USD","SG9999001176.SGD","IE00B4R5TH58.HKD","SG9999001440.SGD","LU1481599808.USD","LU0106261372.USD","LU1037948541.HKD","LU1323610961.USD","LU1917777945.USD","LU0965509101.SGD","LU1064927863.SGD","LU1202635105.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU0130517989.USD","IE00BFXG1179.USD","IE00BLSP4239.USD","LU0061475181.USD","LU0868494617.USD","LU1868836914.USD","LU0321505439.SGD","LU0237698245.USD","IE00BBT3K403.USD","LU1116320737.USD","LU0965509283.SGD","LU1023059063.AUD","LU2133065610.SGD","LU1934455863.HKD","LU1228905540.USD","LU0320765646.SGD","LU2361044949.HKD","LU2468319806.SGD","LU0098860793.USD","LU1974910355.USD","LU1093756325.SGD","IE00BLSP4452.SGD","LU2087621335.USD","LU2089984988.USD","LU0265550946.USD","SG9999002232.USD","LU1228905037.USD","LU1069347547.HKD","LU1093756168.USD","LU0980610538.SGD","RHHBY","BK4139","LU0058720904.USD","LU1162221912.USD","BK5011","BK4588","SG9999014559.SGD","BK4568","LU2361044865.SGD","LU1481600234.SGD","LU1674673428.USD","LU0267386448.USD","LU0306806265.USD","LU1868836591.USD","GILD","SG9999014575.USD","SG9999015358.SGD","LU0861579265.USD","BK4578","LU1201861249.SGD","LU2324357040.USD","LU0321505868.SGD","IE00BKVL7J92.USD","BK4550","LU0882574055.USD","BK4516","LU2360032135.SGD","LU0234570918.USD","IE00BZ1G4Q59.USD","SG9999002224.SGD","IE0009355771.USD","LU2106854487.HKD","LU0109394709.USD","SG9999014567.USD","LU1291159041.SGD","LU1400636657.SGD","LU1487256676.USD","SG9999015986.USD","LU1929549753.HKD","AMGN","LU2112291526.USD","LU1670711040.USD","LU0320765489.SGD","LU2125154935.USD","LU0823416689.USD","LU0965509010.AUD","IE00BWDBJ516.SGD","SG9999015978.USD","LU0208291251.USD","LU1032466523.USD","BK4581"],"gpt_icon":0},{"id":"2592156513","title":"创新药研发充满荆棘,近期多家药企接连宣布“折戟”","url":"https://stock-news.laohu8.com/highlight/detail?id=2592156513","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592156513?lang=zh_cn&edition=full","pubTime":"2025-12-18 16:06","pubTimestamp":1766045160,"startTime":"0","endTime":"0","summary":"创新药被喻为医药行业的“皇冠明珠”,成功上市往往意味着巨额回报与生命希望。如赛诺菲近日公告称,公司研发的治疗晚期多发性硬化症的药物tolebrutinib在一项针对原发性进展型多发性硬化症的后期试验中,未能延迟患者残疾的进展。而在原发性进展型多发性硬化症中,症状会持续恶化,没有任何恢复期。赛诺菲表示将不再就该适应症寻求监管批准,该适应症患者约占患者总数的10%。创新药从早期研发到上市,周期长,成功率低,研发成本高。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218160840a45a82aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218160840a45a82aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0130102774.USD","SG9999014542.SGD","LU0289739699.SGD","LU0234572021.USD","LU1066051225.USD","IE00B1BXHZ80.USD","IE00B2B36J28.USD","LU0122379950.USD","IE00BLSP4239.USD","LU0965508806.USD","LU0320765646.SGD","LU1037948897.HKD","LU2361044949.HKD","LU0266013472.USD","LU2361045086.USD","LU1989772840.SGD","LU2106854487.HKD","LU2125154935.USD","LU0208291251.USD","SG9999002232.USD","LU1699723380.USD","LU1934455277.USD","LU0861579265.USD","BK4533","BK4550","SG9999014575.USD","LU0238689110.USD","IE00BJT1NW94.SGD","BK4588","LU1571399168.USD","BK4585","LU2125154778.USD","LU0203345920.USD","LU0320765489.SGD","LU1093756325.SGD","SGXZ57979304.SGD","BK4007","LU1057294990.SGD","LU0648001328.SGD","LU0965509101.SGD","LU1061106388.HKD","LU1941712348.USD","LU2112291526.USD","LU2324357040.USD","LU1066051498.USD","LU0098860793.USD","IE00BBT3K403.USD","LU1023059063.AUD","LU1162221912.USD","LU2023250843.SGD","LU1983299246.USD","IE00BFTCPJ56.SGD","LU2468319806.SGD","LU1989772923.USD","IE00BSNM7G36.USD","SG9999014559.SGD","BK4559","LU1116320901.HKD","SNY","LU0106261372.USD","SG9999015341.SGD","LU2089984988.USD","SG9999001176.SGD","SG9999001176.USD","LU1585245621.USD","BK4534","LU1934455863.HKD","LU1974910355.USD","LU0985320562.USD","LU0130517989.USD","LU1116320737.USD","LU1929549753.HKD","IE0009355771.USD","LU0265550946.USD","LU0058720904.USD","SG9999002224.SGD","LU0006306889.USD","IE00BLSP4452.SGD","LU2360032135.SGD","LU1035773651.USD","LU0203347892.USD","LU1069347547.HKD","IE00BJJMRZ35.SGD","SG9999014567.USD","LU0965509010.AUD","LU0980610538.SGD","LU1066051811.HKD","LU0265550359.USD","LU2461242641.AUD","SG9999001440.SGD","SG9999013999.USD","LU2023250504.SGD","LU0477156953.USD","LU1934455194.USD","LU2361044865.SGD","LU1093756168.USD","LU0070302665.USD","SG9999015358.SGD","LU1037948541.HKD","BK4516","LU1201861249.SGD","LU0211331839.USD","LU1430594728.SGD","IE00BN8TJ469.HKD","LU1989771016.USD","LU1917777945.USD","LU1066053197.SGD","LU1291159041.SGD","IE00B4R5TH58.HKD","LU0965509283.SGD","LU1941712264.USD","IE000M9KFDE8.USD","560600","IE0002141913.USD"],"gpt_icon":0},{"id":"2592990089","title":"赛诺菲(SNY.US)宣布第二代心肌肌球蛋白抑制剂在华获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2592990089","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592990089?lang=zh_cn&edition=full","pubTime":"2025-12-17 21:11","pubTimestamp":1765977087,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,12月17日,赛诺菲宣布第二代心肌肌球蛋白抑制剂阿夫凯泰获得国家药监局批准上市,用于治疗纽约心脏病协会心功能分级II-III级的梗阻性肥厚型心肌病成人患者,以改善运动能力和症状。阿夫凯泰是一种小分子心肌肌球蛋白抑制剂,由Cytokinetics自主研发。据悉,阿夫凯泰片是肥厚型心肌病领域潜在“同类最佳”的治疗药物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1382794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"赛诺菲(SNY.US)宣布第二代心肌肌球蛋白抑制剂在华获批上市","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4007","BK4585","IE00BFXG1179.USD","SNY","BK4588"],"gpt_icon":0},{"id":"2591935317","title":"1天两笔交易,超26亿美元!制药巨头抢滩自免赛道","url":"https://stock-news.laohu8.com/highlight/detail?id=2591935317","media":"医药魔方","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591935317?lang=zh_cn&edition=full","pubTime":"2025-12-16 12:07","pubTimestamp":1765858063,"startTime":"0","endTime":"0","summary":"临近年关,自身免疫领域迎来两笔重磅交易。12月15日,辉瑞与赛诺菲两大制药巨头相继出手,分别与Adaptive Biotechnologies及Dren Bio达成合作,潜在交易总额超26亿美元,为2025年的BD市场画上浓墨重彩的一笔。该交易包含预付款及高达8.9亿美元的里程碑金额,双方还达成了一项独立的TCR数据授权合作。今年8月,其与基因泰克的个性化TCR细胞疗法合作宣告终止。Dren将获得1亿美元预付款,并有机会获取高达17亿美元的里程碑付款。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216133718a6a810a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216133718a6a810a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PFE","LU0321505439.SGD","LU0985481810.HKD","SG9999002224.SGD","BK4599","IE00BBT3K403.USD","LU1894683264.USD","IE00B19Z3B42.SGD","LU0058720904.USD","LU0306806265.USD","SG9999003800.SGD","LU1066053197.SGD","IE0002270589.USD","BK4585","IE00BLSP4239.USD","LU0234572021.USD","LU1894683348.USD","SNY","LU0225284248.USD","LU0122379950.USD","BK4581","IE00B19Z3581.USD","BK4007","LU0306807586.USD","IE00BLSP4452.SGD","SG9999001176.USD","BK4592","SG9999001176.SGD","LU0289739699.SGD","IE000M9KFDE8.USD","LU0321505868.SGD","LU0170899867.USD","LU1023059063.AUD","SG9999011175.SGD","LU1883839398.USD","BK4588","SGXZ57979304.SGD","BK4534","BK4550","LU0456855351.SGD","LU1057294990.SGD","LU0225771236.USD","BK4568","LU0868494617.USD","SG9999013999.USD","LU1066051498.USD","SG9999002232.USD","BK4533"],"gpt_icon":1},{"id":"2591648196","title":"FDA延期叠加试验失败,赛诺菲多发性硬化症药物遭双重暴击","url":"https://stock-news.laohu8.com/highlight/detail?id=2591648196","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591648196?lang=zh_cn&edition=full","pubTime":"2025-12-15 19:05","pubTimestamp":1765796736,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"adcb97001031eadac4ba887dc4784d4e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"FDA延期叠加试验失败,赛诺菲多发性硬化症药物遭双重暴击","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SNY"],"gpt_icon":0},{"id":"1153946041","title":"独家报道:美国FDA官员通知默沙东、赛诺菲安万特和阿斯利康的RSV抗体疗法将接受新的安全审查","url":"https://stock-news.laohu8.com/highlight/detail?id=1153946041","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153946041?lang=zh_cn&edition=full","pubTime":"2025-12-09 19:01","pubTimestamp":1765278094,"startTime":"0","endTime":"0","summary":"独家报道:美国FDA官员通知默沙东、赛诺菲安万特和阿斯利康的RSV抗体疗法将接受新的安全审查","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0972486137.USD","LU1487256676.USD","LU0058720904.USD","LU0965508806.USD","LU1929549753.HKD","LU1035773651.USD","LU0047473722.SGD","LU1989772923.USD","03165","BK5011","LU0965509283.SGD","LU0963555726.SGD","SG9999014575.USD","LU0320765646.SGD","IE00BBT3K403.USD","LU1037948541.HKD","LU0965509101.SGD","BK4516","LU1066053197.SGD","IE00BJJMRZ35.SGD","LU2539964713.USD","LU1934455863.HKD","LU0792757196.USD","LU1066051225.USD","LU1066051498.USD","LU1699723380.USD","LU0545039389.USD","LU0861579265.USD","SG9999014559.SGD","LU0289739699.SGD","LU1023059063.AUD","LU0158827948.USD","LU1267930490.SGD","IE00BJT1NW94.SGD","SG9999001176.SGD","LU1116320901.HKD","LU0496365809.HKD","LU0047473722.EUR","LU1430594728.SGD","LU0553294199.USD","LU0957799991.USD","LU1585245621.USD","LU0889566641.SGD","LU0757432116.USD","LU1983299246.USD","LU2023251221.USD","LU1116320737.USD","IE00B2B36J28.USD","BK4585","LU0171293334.USD","LU0238689110.USD","LU2106854487.HKD","SG9999002232.USD","LU0211328371.USD","LU2091194634.USD","LU2361044865.SGD","LU0976567544.SGD","AZN","LU0006306889.USD","LU0029864427.USD","LU0823399737.USD","BK4533","LU2361045086.USD","LU0949170772.SGD","LU1496350502.SGD","LU1064927863.SGD","SG9999001440.SGD","LU2125154778.USD","LU0499090636.EUR","LU0310800379.SGD","LU0882574055.USD","LU1003077747.HKD","LU0575583348.USD","SG9999014542.SGD","LU2293690082.USD","LU0265550946.USD","LU0960981461.USD","LU0234572021.USD","LU2468319806.SGD","LU0128525929.USD","LU1301847155.USD","LU2461242641.AUD","SG9999014567.USD","LU0106261372.USD","SG9999013999.USD","LU0266013472.USD","LU0784385840.USD","IE00BFTCPJ56.SGD","LU0128525689.USD","LU0265550359.USD","LU1880407215.USD","LU2089283258.USD","IE000M9KFDE8.USD","LU1323610961.USD","LU1162221912.USD","LU0345777659.USD","LU1093756168.USD","SG9999002224.SGD","LU0708994859.HKD","LU2293690249.USD","BK4007","LU2133065610.SGD","LU1037948897.HKD","LU0114720955.EUR","LU1267930813.SGD","LU0557290698.USD","LU1119994496.HKD","LU0949170426.SGD","LU0526926950.USD","LU1989771016.USD","IE0034235188.USD","LU0985320562.USD","LU0320765489.SGD","IE00BLSP4239.USD","BK4534","LU2324357040.USD","LU0889565080.SGD","LU0965509010.AUD","LU0964806797.USD","LU1291159041.SGD","LU0784383803.USD","LU0969580561.USD","LU1153584641.USD","LU0211327993.USD","LU0070302665.USD","LU1051770623.HKD","LU1934455194.USD","IE0009355771.USD","LU0310799852.SGD","LU2108987350.USD","LU1974910355.USD","IE00BN8TJ469.HKD","LU2023250504.SGD","LU0661504455.SGD","LU2089984988.USD","LU1003076772.USD","LU1104425308.USD","IE00BKPKM643.USD","SGXZ57979304.SGD","SG9999015341.SGD","SNY","LU1267930573.SGD","LU2361044949.HKD","LU2089284900.SGD","LU1057294990.SGD","IE00B4R5TH58.HKD","LU2279689827.SGD","LU0211326839.USD","LU1061106388.HKD","LU1481600234.SGD","BK4588","LU1084165304.USD","LU0011850046.USD","LU1917777945.USD","LU0310800965.SGD","LU1261432733.SGD","SG9999015358.SGD","LU1066051811.HKD","LU2125154935.USD","IE00B1BXHZ80.USD","LU1267930227.SGD","LU0997586432.USD","LU1481599808.USD","IE0002141913.USD","BK4559","LU0738911758.USD","MRK","IE00BLSP4452.SGD","LU1069347547.HKD","LU2112291526.USD","LU0823416689.USD","LU1019632923.USD","LU1078025761.USD","LU1496350171.SGD","LU2360032135.SGD","LU0432979614.USD","IE00BSNM7G36.USD","LU1934455277.USD","LU0640478417.SGD","LU2023250843.SGD","LU1019634622.SGD","LU1814569148.SGD","LU0098860793.USD","LU0203347892.USD","LU0211331839.USD","LU0784385170.HKD","LU0077335932.USD","LU1093756325.SGD","SG9999001176.USD","LU1153585028.USD","LU0784384876.USD","LU0052756011.USD","BK4550","LU0122379950.USD","LU0211326755.USD","LU1989772840.SGD","LU0208291251.USD","LU1941712264.USD","IE00B3T34201.USD","LU1880407132.USD","LU0345777147.USD","LU2114397693.USD","LU0203345920.USD","LU1571399168.USD","LU1015430645.USD","LU1941712348.USD"],"gpt_icon":0},{"id":"2577620165","title":"旗舰药物需求增长,赛诺菲安万特三季度利润超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2577620165","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577620165?lang=zh_cn&edition=full","pubTime":"2025-10-24 14:55","pubTimestamp":1761288921,"startTime":"0","endTime":"0","summary":"重申了全年业绩指引。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1359268.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SNY"],"gpt_icon":0},{"id":"2576055837","title":"EMA十月药品审评会议:赛诺菲(SNY.US)、Insmed(INSM.US)等公司新药获上市推荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2576055837","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576055837?lang=zh_cn&edition=full","pubTime":"2025-10-17 21:29","pubTimestamp":1760707780,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,在本周召开的会议上,欧洲药品管理局的专家小组对赛诺菲与Insmed的两款新药做出了推荐在该地区上市的积极意见。除了推荐新药获批外,该委员会还否决了赛诺菲的一款新药,并推荐了8项新的药品适应症扩展申请。赛诺菲表示,这一决定基于该公司关键的LUNA 3期临床试验。该公司表示,CHMP的这一决定令人失望,并将寻求对该决定进行重新审查。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1356643.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0320765992.SGD","BK4588","EMA","BK4007","LU0109394709.USD","LU0889565916.HKD","LU0053671581.USD","BK4081","BK4585","BK4139","SNY","INSM","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2570302992","title":"赛诺菲(SNY.US)TSLP/IL-13双抗启动COPD II/III期临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2570302992","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570302992?lang=zh_cn&edition=full","pubTime":"2025-09-26 09:05","pubTimestamp":1758848759,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,9月24日,全球临床试验收录网站显示,赛诺菲的TSLP/IL-13双抗Lunsekimig推进至II/III期阶段,针对慢性阻塞性肺病启动了两项II/III期临床试验。研究的主要终点为基线至第48周中重度COPD恶化的年化发生率。此前,赛诺菲曾公布Lunsekimig治疗哮喘的Ib期概念验证研究数据。数据显示,哮喘患者经400mg Lunsekimig治疗28天后,呼出一氧化碳分数较基线显著降低,较安慰剂组降幅为40.9ppb。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1349691.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["III","BK4588","BK4585","IE00BFXG1179.USD","SNY","BK4007","TSLP","BK4134"],"gpt_icon":0},{"id":"2564137720","title":"赛诺菲(SNY.US)全球首创OX40L单抗III期研究成功","url":"https://stock-news.laohu8.com/highlight/detail?id=2564137720","media":"智通财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564137720?lang=zh_cn&edition=full","pubTime":"2025-09-04 21:16","pubTimestamp":1756991799,"startTime":"0","endTime":"0","summary":"赛诺菲(SNY.US)宣布Amlitelimab治疗特应性皮炎的III期COAST 1研究达到了所有主要终点和次要终点。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20250904/20250904211559_80523.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20250904/20250904211559_80523.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1341694.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4007","BK4134","III","SNY","BK4588","IE00BFXG1179.USD","BK4585"],"gpt_icon":0},{"id":"2564327214","title":"美股异动 | 赛诺菲(SNY.US)盘前跌近9% 特应性皮炎药物后期试验疗效不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2564327214","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564327214?lang=zh_cn&edition=full","pubTime":"2025-09-04 17:04","pubTimestamp":1756976650,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,赛诺菲公司用于治疗皮肤疾病“特应性皮炎”的实验性药物在后期试验中令投资者感到失望,因为该药物的疗效低于预期。消息公布后,截至发稿,该股票美股盘前跌幅高达 9.3%。截至周三收盘,该股票在过去 12 个月里已下跌了 18%。赛诺菲正在寻找接替Dupixent的替代药物。itepekimab是由赛诺菲和再生元共同研发的一种药物,目前该药物正在用于测试治疗曾经吸烟者的慢性阻塞性肺疾病。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1341508.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BFXG1179.USD","BK4007","BK4585","BK4588","SNY"],"gpt_icon":0},{"id":"2564327502","title":"美股异动丨赛诺菲盘前大跌超9%,OX40L数据不及预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2564327502","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564327502?lang=zh_cn&edition=full","pubTime":"2025-09-04 17:00","pubTimestamp":1756976447,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4588","BK4007","BK4585","BK4134","IE00BFXG1179.USD","SNY","III","BK5011","0O59.UK"],"gpt_icon":0},{"id":"1121926878","title":"赛诺菲安万特股价因实验药物结果不佳而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=1121926878","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121926878?lang=zh_cn&edition=full","pubTime":"2025-09-04 16:51","pubTimestamp":1756975863,"startTime":"0","endTime":"0","summary":"9月4日(周四)$赛诺菲安万特$股价暴跌,因为其治疗皮肤病的实验药物在晚期试验中结果不佳,令投资者失望。这增加了对赛诺菲在此期间少数几个晚期试验结果的敏感性。德意志银行在最近的一份报告中表示,解决这一问题的主要方法,或者可能是唯一的方法,是Amlitelimab。周四公布的Amlitelimab试验数据显示,经过24周的治疗后,服用该药物的湿疹患者在皮肤清除方面比服用安慰剂的患者有所改善。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"赛诺菲安万特股价因实验药物结果不佳而下跌","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNY"],"gpt_icon":0},{"id":"2564850324","title":"医药巨头赛诺菲安万特盘前大跌超8%公司新型湿疹药物试验结果表现不佳;特朗普家族旗下比特币矿商American Bitco","url":"https://stock-news.laohu8.com/highlight/detail?id=2564850324","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564850324?lang=zh_cn&edition=full","pubTime":"2025-09-04 16:03","pubTimestamp":1756973023,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09042","IE00BFXG1179.USD","09939","09439","BK1161","BK4585","BTC.USD.HKCC","MSTU","BK4594","BK4588","BK4601","03042","03008","IBIT","BK1515","BTC.USD.CC","BK1574","159938","SNY","09008","BK1611","ABTC","03439","MBTmain","BK4007","83042"],"gpt_icon":0},{"id":"2564340109","title":"赛诺菲(SNY.US)的Amlitelimab在3期研究中达到所有主要和关键次要目标。","url":"https://stock-news.laohu8.com/highlight/detail?id=2564340109","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564340109?lang=zh_cn&edition=full","pubTime":"2025-09-04 13:03","pubTimestamp":1756962212,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4007","BK5011","BK4588","0O59.UK","SNY","BK4585","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2562275651","title":"美股生物医药股全线下跌!特朗普再放狠话:下调药品价格1400%至1500%","url":"https://stock-news.laohu8.com/highlight/detail?id=2562275651","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562275651?lang=zh_cn&edition=full","pubTime":"2025-08-26 06:20","pubTimestamp":1756160400,"startTime":"0","endTime":"0","summary":"8月26日,美国总统特朗普周一表示,其政府将大幅下调药品价格,幅度高达1400%至1500%,并重申对医药价格的强硬立场,同时计划对进口药品加征更高关税。这一表态是在特朗普向多家制药巨头发出正式信函近一个月后作出的。特朗普称此举旨在推动制药产业回流美国。今年7月,特朗普曾威胁对进口药征收200%关税,但随后下调了提议。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c5d4bd894299c7bf3aa4d01ffdbe4f66","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1334980.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"医药股全线下跌!特朗普再放狠话:下调药品价格1400%至1500%","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["NVAX","MRNA","PFE","BNTX","MRK","SNY","SRPT","LLY"],"gpt_icon":1},{"id":"2558461999","title":"赛诺菲安万特8月11日成交额为1.31亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558461999","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558461999?lang=zh_cn&edition=full","pubTime":"2025-08-12 14:35","pubTimestamp":1754980509,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日,赛诺菲安万特成交额为1.31亿美元,成交额较昨日减少6.67%,当日成交量为277.11万股。赛诺菲安万特于2025年8月11日涨0.17%,报47.21美元,该股过去5个交易日跌1.75%,年初至今涨2.55%,过去60日跌4.06%。然而,该公司在2019年底决定退出心脏代谢领域,这可能会减少该公司在这一大型治疗领域的足迹。超过40%的总收入来自美国,25%来自欧洲。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812143516a6e10ae8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812143516a6e10ae8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SNY","BK4007","BK4588","BK4585","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2558772506","title":"赛诺菲安万特8月8日成交额为1.40亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558772506","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558772506?lang=zh_cn&edition=full","pubTime":"2025-08-09 14:35","pubTimestamp":1754721355,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日,赛诺菲安万特成交额为1.40亿美元,成交额较昨日减少18.84%,当日成交量为296.83万股。赛诺菲安万特于2025年8月8日跌0.63%,报47.13美元,该股过去5个交易日涨0.81%,年初至今涨2.38%,过去60日跌5.66%。然而,该公司在2019年底决定退出心脏代谢领域,这可能会减少该公司在这一大型治疗领域的足迹。超过40%的总收入来自美国,25%来自欧洲。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809143602a47e7347&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809143602a47e7347&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","IE00BFXG1179.USD","SNY","BK4588","BK4007"],"gpt_icon":0},{"id":"2557543397","title":"赛诺菲安万特8月7日成交额为1.73亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557543397","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557543397?lang=zh_cn&edition=full","pubTime":"2025-08-08 14:31","pubTimestamp":1754634717,"startTime":"0","endTime":"0","summary":"美东时间2025年8月7日,赛诺菲安万特成交额为1.73亿美元,成交额较昨日增加6.51%,当日成交量为365.10万股。赛诺菲安万特于2025年8月7日涨2.71%,报47.43美元,该股过去5个交易日涨3.92%,年初至今涨3.03%,过去60日跌7.11%。然而,该公司在2019年底决定退出心脏代谢领域,这可能会减少该公司在这一大型治疗领域的足迹。超过40%的总收入来自美国,25%来自欧洲。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808143200a6da5e4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808143200a6da5e4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4585","IE00BFXG1179.USD","BK4588","SNY"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sanofi.com","stockEarnings":[{"period":"1week","weight":-0.0103},{"period":"1month","weight":-0.0276},{"period":"3month","weight":0.0113},{"period":"6month","weight":0.0067},{"period":"1year","weight":0.0143},{"period":"ytd","weight":-0.001}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1452},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1613}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Sanofi于1994年根据法国法律注册成立。该公司是一家全球领先的医疗保健公司,专注于患者需求并从事治疗解决方案的研究、开发、制造和营销。该公司的活动围绕以下类别组织:DUPIXENT、神经病学&免疫学、罕见病、肿瘤学、罕见血液病、普药核心资产和非核心资产、疫苗、CHC。","yearOnYearQuotes":[{"month":1,"riseRate":0.521739,"avgChangeRate":-0.016351},{"month":2,"riseRate":0.304348,"avgChangeRate":-0.020169},{"month":3,"riseRate":0.826087,"avgChangeRate":0.032485},{"month":4,"riseRate":0.652174,"avgChangeRate":0.024644},{"month":5,"riseRate":0.521739,"avgChangeRate":-0.004852},{"month":6,"riseRate":0.434783,"avgChangeRate":-0.014772},{"month":7,"riseRate":0.478261,"avgChangeRate":0.015469},{"month":8,"riseRate":0.5,"avgChangeRate":-0.007213},{"month":9,"riseRate":0.541667,"avgChangeRate":0.007782},{"month":10,"riseRate":0.541667,"avgChangeRate":-0.000294},{"month":11,"riseRate":0.583333,"avgChangeRate":-0.002306},{"month":12,"riseRate":0.666667,"avgChangeRate":0.028955}],"exchange":"NASDAQ","name":"赛诺菲安万特","nameEN":"Sanofi SA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"赛诺菲安万特(SNY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供赛诺菲安万特(SNY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"赛诺菲安万特,SNY,赛诺菲安万特股票,赛诺菲安万特股票老虎,赛诺菲安万特股票老虎国际,赛诺菲安万特行情,赛诺菲安万特股票行情,赛诺菲安万特股价,赛诺菲安万特股市,赛诺菲安万特股票价格,赛诺菲安万特股票交易,赛诺菲安万特股票购买,赛诺菲安万特股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"赛诺菲安万特(SNY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供赛诺菲安万特(SNY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}